|Mr. John H. Hammergren||Chairman, CEO & Pres||8.3M||72.18M||58|
|Mr. James A. Beer||CFO & Exec. VP||2.48M||N/A||56|
|Mr. Jorge L. Figueredo||Exec. VP of HR||2M||1.13M||56|
|Mr. Paul C. Julian||Exec. VP||4.68M||N/A||62|
|Ms. Kathleen D. McElligott||Chief Technology Officer, Chief Information Officer and Exec. VP||N/A||N/A||61|
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
McKesson Corporation’s ISS Governance QualityScore as of August 1, 2017 is 8. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 4; Compensation: 10.